Phase I safety and immunogenicity study of a Brazilian serogroup B vaccine

Meningococcal disease by serogroup B has been a public health problem in Brazil in the last decades. The Brazilian Oswaldo Cruz Foundation has been working to develop a vaccine with detergent-treated outer membrane vesicles (OMV) and detoxified endotoxin (dLOS) from Neisseria meningitidis serogroup...

Descripción completa

Detalles Bibliográficos
Autores principales: Martins, R. Menezes, Périssé, A.R.S., Camacho, L.A.B., Leal, M.L., Maia, M.L.S., Homma, A., Jessouroun, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392203/
https://www.ncbi.nlm.nih.gov/pubmed/34793713
http://dx.doi.org/10.1016/j.bjid.2021.101652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392203/
https://www.ncbi.nlm.nih.gov/pubmed/34793713
http://dx.doi.org/10.1016/j.bjid.2021.101652

Ejemplares similares